Moreover, mutations of IDH1 and IDH2 have been detected in many types of cancer, including gliomas and myeloid malignant tumors; furthermore, these enzymes have been confirmed to be closely related to the occurrence and development of cancer [31]. The gene discussed is IDH1; the disease is central nervous system cancer.